A phase I trial of ganetespib in combination with paclitaxel and trastuzumab in patients with human epidermal growth factor receptor-2 (HER2)-positive metastatic breast cancer

Overview of attention for article published in Breast Cancer Research, August 2017

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (63rd percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 1 X user

patent: 1 patent

Citations

dimensions_citation: 50 Dimensions

Readers on

mendeley: 74 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

Combination therapy of HSP90 inhibitors and PD-1 inhibitors for treating cancer

Grant US-11497733-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.